课题基金 / 基金详情

PYRIMIDINE AND RIBOSE THERAPY IN DISORDERS OF NUCLEOTIDE METABOLISM

PYRIMIDINE AND RIBOSE THERAPY IN DISORDERS OF NUCLEOTIDE METABOLISM
嘧啶和核糖治疗核苷酸代谢紊乱
批准号:
6117910
负责人:
Alice L. Yu
金额:
$1.46万
依托单位国家:
美国
项目类别:
财政年份:
1998
资助国家:
美国
项目状态:
已结题
起止时间:
1998-12-01 至 1999-11-30

项目摘要

项目成果

Alice L. Yu的其他基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
To determine the potential beneficial effects of oral riboside therapy in patients who have not been placed on uridine/thymidine therapy, to test beneficial effects of adding or switching to uridine in patients and to determine the potential benefit of adding oral ribose to patients who are currently on uridine/thymidine therapy.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Predicting toxicity and success of anti-GD2 immunotherapy of neuroblastoma
Predicting toxicity and success of anti-GD2 immunotherapy of neuroblastoma
Immune Monitor-- COG Trial of Anti-GD2 in Neuroblastoma
IMMUNE MONITOR FOR COG TRIAL OF ANTI-GD2 IN NEUROBLASTOMA